TechVision Fonds — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
PL BioSciencepl-bioscience.comin𝕏Aug 2024
PL BioScience develops human platelet-based cell culture media that promote cell growth, used in biotechnology research and cell culture applications.
BiotechNew Materials
Dr. Hatim Hemeda(Founder & CEO)
Co-investorsAvant BioBetter VenturesBrightlands Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.